S100A16 and pachyonychia congenita: In conclusion, the current findings provide new mechanistic insights into PC aggressiveness and GEM resistance, suggesting the critical role of circ_0036627/miR‐145/S100A16 axis in PC progression and drug resistance development and offering novel therapeutic targets for PC therapy.